Breaking News on Global Pharmaceutical Technology & Manufacturing

Top Headlines

Gangsters imported fake drugs from Asia says Europol

Erectile dysfunction drugs seized in Europe wide counterfeit crackdown today

Millions of fake pharmaceuticals seized earlier today were imported from Asia by an organised crime group that planned to sell them online say European law enforcement agencies that co-ordinated the swoop. 

Related news

News in brief

Pharma firms must provide imaginative solid dosage alternatives to tablets and capsules, says researching claiming more than half of patients have problems swallowing traditional pills.

A German biobank has made stem cells available to API firms this week in a bid to support industry drug development efforts.

The US FDA has criticised the Compounding Shop and Zion Rx Formulations Services for making unapproved and contaminated drugs.

The US FDA import ban imposed on Apotex in 2009 was legal and the firm was not treated more harshly than generics rival Teva according to a State Department arbitration panel.

Novo Nordisk has bought a biomanufacturing facility earmarked for closure by Olympus Biotech and begun rehiring staff in order to support its haemophilia product pipeline.

Global Industry News


2020 vision: A look at the future of the biosimilars market from takes a look at the players, patent expiries and legal wrangles that will dominate the biosimilars market over the next few years. 

Single-use growth outpacing stainless steel, says acquisition-hungry Pall from

Acquisitions in the single-use tech space helped drive growth in fiscal 2014 according to Pall, which plans to continue its two-pronged M&A strategy.

Breed lab mice with wild for better neuro research say scientists from

The drive for homogenous animal models in preclinical research has robbed mice of useful behavioural traits, say scientists.

Clinical trials: the technology catching cheating volunteers from

Contract research organisations (CROs) are turning to technology to fight dual patient enrolment in trials, but rival service companies refuse to sync their methods, says an early-phase expert.

EDC more critical in biopharma trials than small mol studies says expert from

Smaller pipelines make keeping to timelines particularly important in biopharmaceutical trials according to Exco InTouch, which says this pressure is driving EDC tech adoption.


SCM's woes part of UK-wide aseptic slowdown, says ex-owner

SCM's woes part of UK-wide aseptic slowdown, says ex-owner

GMP failures at an aseptic plant owned by SCM Pharma are part of a wider industry trend...

Boehringer aims to cut German costs 15% as H1 sales fall

Boehringer Ingelheim aims to cut German costs 15% as revenues drop

German jobs are safe despite a programme that will cut the cost of operations by 15%, Boehringer...

WHO: Data from use of unapproved Ebola drugs should be shared

WHO: Data from use of unapproved Ebola drugs should be shared

Efficacy and safety data from use of unapproved Ebola virus treatments should be shared according to an...

THC may reduce tumor size? mouse study investigates

THC may reduce tumor size? mouse study investigates

A previously unknown signaling platform may be responsible for the success of the main psychoactive ingredient in...

India’s CDSCO outlines procedures for state manufacturer inspections

India’s CDSCO outlines procedures for state inspections of manufacturers

In order to ensure uniformity on the state and federal levels, India’s CDSCO (Central Drugs Standard Control...

Roche re-enters RNAi space with $250m Santaris acquisition

Roche re-enters gene silencing space with $250m LNA acquisition

Roche has renewed its interest in gene silencing drugs, paying $250m (€187m) for Santaris Pharma including its...

Key Industry Events


Access all events listing

Our events, Events from partners...